Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 679Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Holder DMF No. Subject Submission Date Status Type GDUFA DMF Review GDUFA Review Date GDUFA Payment Date
    29/11/2025 Pfizer CentreOne
    U.S.A
    		 PHARMACIA AND UPJOHN CO LLC WHOLLY OWNED SUB OF PFIZER INC 6525 DEXAMETHASONE SODIUM PHOSPHATE USP 1986-08-11 Active II Complete 2022-03-04 2022-02-28
    29/11/2025 Symbiotec Pharmalab
    India
    		 SYMBIOTEC PHARMALAB PRIVATE LIMITED 42465 DEXAMETHASONE SODIUM PHOSPHATE USP 2025-09-15 Active II N/A